SyVento BioTech is pleased to announce the planned collaboration with NanoSanguis S.A. on the implementation of the project โ๐ก๐ฎ๐ป๐ข๐ซ ๐ฐ ๐๐ถ๐ฑ๐ป๐ฒ๐ – ๐ฎ ๐ป๐ฒ๐ ๐-๐ด๐ฒ๐ป๐ฒ๐ฟ๐ฎ๐๐ถ๐ผ๐ป ๐ธ๐ถ๐ฑ๐ป๐ฒ๐ ๐ฝ๐ฒ๐ฟ๐ณ๐๐๐ถ๐ผ๐ป ๐ณ๐น๐๐ถ๐ฑ ๐ฏ๐ฎ๐๐ฒ๐ฑ ๐ผ๐ป ๐ฎ ๐๐๐ป๐๐ต๐ฒ๐๐ถ๐ฐ ๐ผ๐ ๐๐ด๐ฒ๐ป ๐ฐ๐ฎ๐ฟ๐ฟ๐ถ๐ฒ๐ฟ.โ
Under the anticipated agreement, SyVento will provide comprehensive technological and analytical support for the development and manufacturing process of a Class III medical device. This includes the preparation and delivery of complete technical and quality documentation required for conformity assessment.
The project focuses on the development of NanOX 4 Kidney, a sterile oil-in-water nanoemulsion designed as a perfusion fluid for use in preclinical and clinical studies. As part of the collaboration, SyVento will deliver technical support of the manufacturing process, including analytics and the production of preclinical andย clinical batches.
This partnership reflects our shared commitment to advancing cutting-edge medical technologies and supporting the development of innovative solutions in organ preservation and transplantation.
